According to the most recent analysis by Emergen Research, the market for human microbiome modulators had a value of USD 106.56 million in 2021 and is projected to grow at a rate of 24.3% over the forecast period. Between 2021 and 2030, rising investments in healthcare infrastructure and an increase in lifestyle illnesses are two major drivers anticipated to promote market revenue growth.
To receive a PDF sample of the report, visit @